Viewing nowOlmesartan Medoxomil 10mg Tablets
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

MFDS item code 201100799 · Approved 2011.02.21 · Insurance code 653402230
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure remains persistently high, which can pose a risk to heart and vascular health. This medication helps to lower blood pressure, reducing the burden on blood vessels and the heart, and aids in preventing complications arising from hypertension. Continuing to take this medicine is effective for blood pressure control and improves overall cardiovascular health. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with known allergies to this drug or its components, in pregnant or breastfeeding women, in patients undergoing kidney dialysis, in patients with severe liver impairment, in patients with biliary obstruction, in certain genetically predisposed lactose intolerant patients, or in specific diabetes patients. Patients with reduced blood volume or low salt, those with impaired kidney function, kidney transplant recipients, patients with renovascular hypertension, patients at risk for hyperkalemia, and patients with specific heart diseases should use this medication cautiously and be closely monitored when initiating treatment. This drug may cause relatively mild side effects such as dizziness, headache, indigestion, and cough, while rare serious side effects like angioedema or liver function abnormalities have also been reported. If symptoms such as chronic diarrhea, weight loss, or abdominal pain occur during treatment, medical consultation should be sought immediately, and if intestinal vascular edema occurs, the medication should be discontinued and careful observation should continue until symptoms fully resolve. Care should be taken to consult with a professional when taking this medication with other antihypertensives, potassium-sparing diuretics, potassium supplements, lithium, or nonsteroidal anti-inflammatory painkillers, due to potential interactions leading to side effects. The medication should be avoided during pregnancy due to the risk of serious harm or death to the fetus, and breastfeeding mothers should also discontinue either breastfeeding or the medication if adverse reactions occur in the baby. Safety and efficacy in pediatric patients have not been sufficiently established; thus, it is advisable not to use it in children. Elderly patients should be cautious as drug concentrations in the body may be higher. In cases of overdose, symptoms may include hypotension, palpitations, and bradycardia, and immediate medical attention should be sought. This medication has not been shown to be carcinogenic after long-term use, but if any unusual symptoms occur while taking it, it is important to consult a specialist immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 25 degrees Celsius to preserve the drug's efficacy over time.
White round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.